Tolterodine Tartrate

Product NDC
0378-3404
Requested package NDC
0378-3404-05
11-digit product format
003783404
Labeler code
0378
Product ID
0378-3404_03852abe-992e-4d0b-a105-19ca8faba01e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tolterodine Tartrate
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Mylan Pharmaceuticals Inc.
Application
ANDA201486
Marketing category
ANDA
Marketing start
2013-10-31
Marketing end
0000-00-00
Substance
TOLTERODINE TARTRATE
Active strength
4 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0378-34040378-3404-05DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A201486-001TOLTERODINE TARTRATETOLTERODINE TARTRATE2MGCAPSULE, EXTENDED RELEASE / ORAL2013-10-31
A201486-002TOLTERODINE TARTRATETOLTERODINE TARTRATE4MGCAPSULE, EXTENDED RELEASE / ORAL2013-10-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A201486-001TOLTERODINE TARTRATE2MGCAPSULE, EXTENDED RELEASE / ORAL2013-10-31a50c72e98297…
2026-08-01 22:54:322026-06A201486-002TOLTERODINE TARTRATE4MGCAPSULE, EXTENDED RELEASE / ORAL2013-10-31a50c72e98297…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0378-3404-05EA - Each0378-340461874735-3f4d-4de2-9ad8-bdc10b5b7b0612014-02-04
0378-3404-77EA - Each0378-340432822b0a-6817-4252-8065-c4376224ba1f12014-02-04
0378-3404-93EA - Each0378-3404a76c770c-45a1-4ef1-8f84-1e7b6227ae6312014-02-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TOLTERODINE TARTRATEACTIVE INGREDIENT5T619TQR3RTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
TOLTERODINEACTIVE MOIETYWHE7A56U7KTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
GELATININACTIVE INGREDIENT2G86QN327LTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
SHELLACINACTIVE INGREDIENT46N107B71OTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
SUCROSEINACTIVE INGREDIENTC151H8M554TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
TALCINACTIVE INGREDIENT7SEV7J4R1UTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]3
TOLTERODINE TARTRATEACTIVE INGREDIENT5T619TQR3RTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
TOLTERODINEACTIVE MOIETYWHE7A56U7KTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
GELATININACTIVE INGREDIENT2G86QN327LTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
SHELLACINACTIVE INGREDIENT46N107B71OTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
SUCROSEINACTIVE INGREDIENTC151H8M554TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
TALCINACTIVE INGREDIENT7SEV7J4R1UTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0378-3404-0500378340405500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-3404-05) 2013-10-310000-00-00NoNoCurrent